Encompass Health Corporation
Encompass Health Corporation provides a variety of post-acute healthcare services across the United States, delivered both in dedicated facilities and directly within patients' homes. The company operates through two primary divisions. The Inpatient Rehabilitation division specializes in providing focused recovery…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
1D
+0.1%
1W
+3.7%
1M
+3.2%
6M
+20.2%
YTD
+20.5%
1Y
+4.0%
2Y
+31.3%
5Y
+137.9%
10Y
+299.7%
Next earnings date
28/10/2026 (in 11 days)
Volatility around earnings
~26% stronger price swings than usual
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 14/10/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BullishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
PRICE TARGET LOW
US$144.00
CONSENSUS
US$150.20
MEDIAN
US$150.00
PRICE TARGET HIGH
US$155.00
1
STRONG BUY
21
BUY
4
HOLD
1
SELL
0
STRONG SELL
27
TOTAL · Buy
As of: 10/08/2026
P/E
20.56
P/B
4.86
EV/EBITDA
10.23
RETURN ON EQUITY
5.9%
NET MARGIN
9.6%
DEBT/EQUITY
1.09
DIVIDEND YIELD
0.6%
AS OF
30/06/2026
FREE FLOAT
99.0%
FLOAT SHARES
97,652,660
AVG. DAILY VOLUME (30D)
909,826
Price Andrew L
Darby John Patrick
Darby John Patrick
COLTHARP DOUGLAS E
Tarr Mark J
Encompass Health Corporation is a company in the Healthcare sector, Medical - Care Facilities industry, headquartered in United States.
The CEO is Mark J. Tarr, the company employs around 29,699 people.
The IPO was on 24/09/1986; the stock trades on NYSE under the ticker EHC.
27 analysts rate the stock, the consensus is Buy (as of 10/08/2026).
The average price target is US$150.20, ranging from US$144.00 to US$155.00, with a median of US$150.00.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 28/10/2026.
Around past earnings, price swings were roughly 26% stronger than usual.
Yes. The last dividend was US$0.21 per share, ex-date 01/10/2026, paid on 15/10/2026.
The dividend yield is 0.6% (as of 30/06/2026).
Comparable stocks include HCA Healthcare, Tenet Healthcare, DaVita, Universal Health Services, Hims & Hers Health, LifeStance Health Group, Concentra Group Holdings Parent and Acadia Healthcare Company.
Clicking "Analyze stock" lets five strategies assess Encompass Health against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.